• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of gutGutCurrent TOCInstructions to authors
Gut. Jun 1995; 36(6): 922–926.
PMCID: PMC1382634

Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis.


The putative relationship between genetic haemochromatosis and PiZ alpha 1 antitrypsin deficiency was studied using a monoclonal antibody against the PiZ variant in 67 consecutive patients with genetic haemochromatosis seen at Karolinska Hospital and Huddinge University Hospital, Stockholm over a 10 year period. Three (4.5%) of the patients with haemochromatosis were found to be PiZ homozygotes (odds ratio = 82, confidence interval = 26, 256; p < 0.0001). The prevalence of the heterozygous (PiZ) phenotype was similar to that in the general population (p = 0.937). During the ascertainment period, liver biopsy was performed in 65 (97%) of the patients; 66% (2 of 3) of the PiZ homozygotes were found to have cirrhosis compared with 10% (6/59) of the non-carriers of the PiZ variant (p = 0.039). None of the homozygous or heterozygous alpha 1 antitrypsin deficient patients had developed hepatocellular carcinoma compared with 3.4% (2 of 59) of the non-PiZ gene carriers (p = 1.0). Two of those with the homozygous phenotype had developed severe emphysema. HLA typing was performed in 18 patients, 16 (89%) of whom manifested antigens known to be linked to haemochromatosis. There were no significant differences between the PiZ gene carriers and non-carriers in mean age at onset of disease, sex distribution, or HLA type. Two of the PiZ heterozygotes had plasma alpha 1 antitrypsin concentrations below the normal range, though the group mean was lower than that of the non-PiZ carriers (p = 0.0003). The data suggest that the presence of the PiZ allele for alpha1 antitrypsin deficiency, in a double dose, is associated with genetic haemochromatosis and may contribute to the earlier onset of cirrhosis in these patients, though it does not increase the risk of hepatocellular carcinoma.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (963K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Edwards CQ, Griffen LM, Kushner JP. Southern blood club symposium: an update on selected aspects of hemochromatosis. Am J Med Sci. 1990 Oct;300(4):245–250. [PubMed]
  • Simon M, Fauchet R, Hespel JP, Beaumont C, Brissot P, Hery B, Hita De Nercy Y, Genetet B, Bourel M. Idiopathic hemochromatosis: a study of biochemical expression in 247 heterozygous members of 63 families: evidence for a single major HLA-linked gene. Gastroenterology. 1980 Apr;78(4):703–708. [PubMed]
  • Lindmark B, Eriksson S. Regional differences in the idiopathic hemochromatosis gene frequency in Sweden. Acta Med Scand. 1985;218(3):299–304. [PubMed]
  • Hallberg L, Björn-Rasmussen E, Jungner I. Prevalence of hereditary haemochromatosis in two Swedish urban areas. J Intern Med. 1989 Apr;225(4):249–255. [PubMed]
  • Brantly M, Nukiwa T, Crystal RG. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med. 1988 Jun 24;84(6A):13–31. [PubMed]
  • Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med. 1986 Mar 20;314(12):736–739. [PubMed]
  • Anand S, Schade RR, Bendetti C, Kelly R, Rabin BS, Krause J, Starzl TE, Iwatsuki S, Van Thiel DH. Idiopathic hemochromotosis and alpha-1-antitrypsin deficiency: coexistence in a family with progressive liver disease in the proband. Hepatology. 1983 Sep-Oct;3(5):714–718. [PMC free article] [PubMed]
  • Eriksson S, Lindmark B, Hanik L. A Swedish family with alpha 1-antitrypsin deficiency, haemochromatosis, haemoglobinopathy D and early death in liver cirrhosis. J Hepatol. 1986;2(1):65–72. [PubMed]
  • Rabinovitz M, Gavaler JS, Kelly RH, Van Thiel DH. Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis. Hepatology. 1992 Jul;16(1):145–148. [PubMed]
  • Eriksson S, Lindmark B, Olsson S. Lack of association between hemochromatosis and alpha-antitrypsin deficiency. Acta Med Scand. 1986;219(3):291–294. [PubMed]
  • Kaserbacher R, Propst T, Propst A, Graziadei I, Judmaier G, Vogel W. Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis. Hepatology. 1993 Sep;18(3):707–708. [PubMed]
  • Wallmark A, Alm R, Eriksson S. Monoclonal antibody specific for the mutant PiZ alpha 1-antitrypsin and its application in an ELISA procedure for identification of PiZ gene carriers. Proc Natl Acad Sci U S A. 1984 Sep;81(18):5690–5693. [PMC free article] [PubMed]
  • Jeppsson JO, Laurell CB, Fagerhol M. Properties of isolated human alpha1-antitrypsins of Pi types M, S and Z. Eur J Biochem. 1978 Feb 1;83(1):143–153. [PubMed]
  • Laurell CB. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. [PubMed]
  • Williams HL, Johnson DJ, Haut MJ. Simultaneous spectrophotometry of Fe2+ and Cu2+ in serum denatured with guanidine hydrochloride. Clin Chem. 1977 Feb;23(2 Pt 1):237–240. [PubMed]
  • Hultcrantz R, Glaumann H. Studies on the rat liver following iron overload: biochemical studies after iron mobilization. Lab Invest. 1982 Apr;46(4):383–392. [PubMed]
  • Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol. 1978 Feb;69(2):103–120. [PubMed]
  • Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976 Jun 10;294(24):1316–1321. [PubMed]
  • Berg NO, Eriksson S. Liver disease in adults with alpha-1 -antitrypsin deficiency. N Engl J Med. 1972 Dec 21;287(25):1264–1267. [PubMed]
  • Crowley JJ, Sharp HL, Freier E, Ishak KG, Schow P. Fatal liver disease associated with alpha 1-antitrypsin deficiency PiM1/PiMduarte. Gastroenterology. 1987 Aug;93(2):242–244. [PubMed]
  • RIGAS DA, FINCH SC. Electrophoretic studies of serum proteins in hemochromatosis. Am J Med Sci. 1959 May;237(5):566–574. [PubMed]
  • Hultcrantz R, Mengarelli S. Ultrastructural liver pathology in patients with minimal liver disease and alpha 1-antitrypsin deficiency: a comparison between heterozygous and homozygous patients. Hepatology. 1984 Sep-Oct;4(5):937–945. [PubMed]
  • Loebermann H, Tokuoka R, Deisenhofer J, Huber R. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol. 1984 Aug 15;177(3):531–557. [PubMed]
  • McCracken AA, Kruse KB, Brown JL. Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342. Mol Cell Biol. 1989 Apr;9(4):1406–1414. [PMC free article] [PubMed]
  • Carlson JA, Rogers BB, Sifers RN, Finegold MJ, Clift SM, DeMayo FJ, Bullock DW, Woo SL. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest. 1989 Apr;83(4):1183–1190. [PMC free article] [PubMed]
  • Perlmutter DH. The cellular basis for liver injury in alpha 1-antitrypsin deficiency. Hepatology. 1991 Jan;13(1):172–185. [PubMed]
  • Bacon BR, Park CH, Brittenham GM, O'Neill R, Tavill AS. Hepatic mitochondrial oxidative metabolism in rats with chronic dietary iron overload. Hepatology. 1985 Sep-Oct;5(5):789–797. [PubMed]
  • Stremmel W, Riedel HD, Niederau C, Strohmeyer G. Pathogenesis of genetic haemochromatosis. Eur J Clin Invest. 1993 Jun;23(6):321–329. [PubMed]
  • Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 1986 Jan-Feb;6(1):24–29. [PubMed]
  • Eriksson S. Alpha 1-antitrypsin deficiency and liver cirrhosis in adults. An analysis of 35 Swedish autopsied cases. Acta Med Scand. 1987;221(5):461–467. [PubMed]
  • Summers KM, Halliday JW, Powell LW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology. 1990 Jul;12(1):20–25. [PubMed]

Articles from Gut are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • OMIM
    OMIM record citing PubMed
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...